SEC CIK 1709113
Cavanaugh Sarah
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CLDXview stock → | 12,610 | 2024-05-30 |
Position History — CLDX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CLDX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-06-25 | Grant / award (derivative) | 95,000 | $0.00 | 95,000 |
| 2025-06-05 | Grant / award (derivative) | 78,000 | $0.00 | 78,000 |
| 2024-06-13 | Grant / award (derivative) | 78,000 | $0.00 | 78,000 |
| 2024-05-30 | Option exercise (derivative) | 10,750 | $0.00 | 0 |
| 2024-05-30 | Option exercise | 10,750 | $2.78 | 12,610 |
| 2024-05-30 | Option exercise | 10,103 | $9.02 | 22,713 |
| 2024-05-30 | Open-market sale | 20,853 | $33.73 | 1,860 |
| 2023-06-15 | Grant / award (derivative) | 75,000 | $0.00 | 75,000 |
| 2022-08-18 | Option exercise (derivative) | 1,355 | $0.00 | 10,103 |
| 2022-08-18 | Open-market sale | 1,355 | $36.38 | 1,284 |
| 2022-08-18 | Option exercise | 1,355 | $9.02 | 2,639 |
| 2022-08-17 | Option exercise (derivative) | 31,312 | $0.00 | 10,750 |
| 2022-08-17 | Option exercise | 31,312 | $2.78 | 32,596 |
| 2022-08-17 | Open-market sale | 31,312 | $36.73 | 1,284 |
| 2022-06-16 | Grant / award (derivative) | 73,000 | $0.00 | 73,000 |
| 2021-12-08 | Option exercise (derivative) | 5,466 | $0.00 | 78,534 |
| 2021-12-08 | Option exercise (derivative) | 1,857 | $0.00 | 11,458 |
| 2021-12-08 | Option exercise | 5,466 | $10.38 | 7,731 |
| 2021-12-08 | Open-market sale | 7,323 | $40.00 | 408 |
| 2021-12-08 | Option exercise | 1,857 | $9.02 | 2,265 |
| 2021-11-01 | Option exercise (derivative) | 5,018 | $0.00 | 13,315 |
| 2021-11-01 | Option exercise (derivative) | 938 | $0.00 | 42,062 |
| 2021-11-01 | Option exercise | 938 | $2.78 | 7,731 |
| 2021-11-01 | Open-market sale | 4,302 | $44.11 | 3,429 |
| 2021-11-01 | Open-market sale | 2,120 | $41.62 | 408 |
| 2021-11-01 | Open-market sale | 901 | $43.06 | 2,528 |
| 2021-11-01 | Option exercise | 5,018 | $9.02 | 6,793 |
| 2021-06-17 | Grant / award (derivative) | 56,000 | $0.00 | 56,000 |
| 2020-06-18 | Grant / award (derivative) | 84,000 | $0.00 | 84,000 |
| 2020-06-10 | Open-market buy | 1,050 | $4.83 | 1,367 |
| 2019-06-19 | Grant / award (derivative) | 43,000 | $0.00 | 43,000 |
| 2018-06-13 | Grant / award (derivative) | 275,000 | $0.00 | 275,000 |
| 2017-06-15 | Grant / award (derivative) | 65,000 | $0.00 | 65,000 |
| 2017-06-15 | — | — | — | 4,760 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.